Interactions of GABA A receptor activation and light on period mRNA expression in the suprachiasmatic nucleus.
Activation of gamma-aminobutyric acid (GABA) A receptors in the suprachiasmatic nucleus (SCN) resets the circadian clock during the day and inhibits the ability of light to reset the clock at night. Light in turn acts during the day to inhibit the phase-resetting effects of GABA. Some evidence suggests that Period mRNA changes in the SCN are responsible for these interactions between light and GABA. Here, the hypothesis that light and the GABA A receptor interact by altering the expression of Period 1 and/or Period 2 mRNA in the SCN is tested. The GABA A agonist muscimol was injected near the SCN just prior to a light pulse, during the mid-subjective day and the early and late subjective night. Changes in Period 1 and Period 2 mRNA were measured in the SCN by in situ hybridization. Light-induced Period 1 mRNA was inhibited by GABA A receptor activation in the early and late subjective night, while Period 2 mRNA was only inhibited during the late night. During the subjective day, light had no effect on the ability of muscimol to suppress Period 1 mRNA hybridization signal. Thus, light and GABA A receptor activation inhibit each other's ability to induce behavioral phase shifts throughout the subjective day and night. However, only in the late night are these behavioral effects correlated with changes in Period gene expression. Together, our data support the hypothesis that the interacting effects of light and GABA are the result of the opposing actions of these stimuli on Period mRNA, but only during the subjective night.
Ehlen
J Christopher
JC
Department of Biology, Georgia State University, Atlanta, GA, USA. jehlen@msm.edu
Novak
Colleen M
CM
Karom
Mary C
MC
Gamble
Karen L
KL
Albers
H Elliott
HE
D000818:Animals; D001345:Autoradiography; D006224:Cricetinae; D003627:Data Interpretation, Statistical; D005136:Eye Proteins / Q000096:biosynthesis* / Q000235:genetics; D018755:GABA Agonists / Q000494:pharmacology; D058785:GABA-A Receptor Agonists; D017403:In Situ Hybridization; D008027:Light; D008297:Male; D008647:Mesocricetus; D009118:Muscimol / Q000494:pharmacology; D056950:Period Circadian Proteins; D012333:RNA, Messenger / Q000096:biosynthesis* / Q000235:genetics; D011963:Receptors, GABA-A / Q000502:physiology*; D013493:Suprachiasmatic Nucleus / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects
D005136:Eye Proteins; D018755:GABA Agonists; D058785:GABA-A Receptor Agonists; D056950:Period Circadian Proteins; D012333:RNA, Messenger; D011963:Receptors, GABA-A; D009118:Muscimol